Evidence map›Paper›PMID 31955388›Full record

ReviewProbiotics and antimicrobial proteins2020

What Is Wrong with Enterococcal Probiotics?

Alexander Suvorov

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Effects of Mink-OriginAnimals : an open access journal from MDPI · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. In Vitro Anti-Microorganisms · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Microbiological Testing of Probiotic Preparations.International journal of environmental research and public health · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alexander SuvorovInstitute of Experimental Medicine, Saint-Petersburg, Russia. Alexander_suvorov1@hotmail.com.ORCID 0000-0003-2312-5589

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enterococci, being the common part of indigenous human microbiota and present in numerous fermented food products and probiotics, are often positioned as health-threatening bacterial pathogens. This makes medical community, especially part of it which is not involved in microbiology research, in an uncertainty regarding the legitimacy of using enterococcal probiotics in medical practice or even consuming them in foods such as cheese or salami. However, the difference between the clinical strains and strains used as probiotics is more than significant. The present paper tries to shed light on enterococci based on the contemporary knowledge of molecular microbiology.

Indexed as

Consumer Product SafetyEnterococcusFood MicrobiologyGastrointestinal MicrobiomeProbioticsCheeseDrug Resistance, BacterialHumansMeat ProductsVirulenceEnterococcusGenomeInfectionProbioticsSafetyTransformation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.